Scaleup Europe Fund (SEF): Tackling Europe’s Scaleup Gap
For years, Europe has long been effective at creating startups, but less successful at keeping them as they grow. The early stages of the innovation cycle are strong. Research is world-class, and funding programmes consistently support promising deep tech ventures. The weakness appears later, when companies need to scale. At that point, capital requirements increase sharply, often reaching €100 million or more, and the focus shifts from technology to industrial deployment and global expansion.
This is where many European companies face a structural gap. Large, late-stage capital is still limited in Europe, especially compared to the US. As a result, scaleups frequently turn to international investors. Over time, this can lead to a shift in ownership, decision-making, and sometimes location.
Europe not only loses companies but risks losing strategic technologies, talent, and long-term economic value. The newly announced Scaleup Europe Fund (SEF) is a direct response to tackling that problem.
The funding gap in practice
As companies move beyond Series A and B, funding rounds become larger and fewer investors are able to participate. While Europe offers strong support at the early stage, access to concentrated capital becomes more constrained at the growth stage. This creates a break in continuity. Companies that have been built and supported in Europe often need to look outside the EU to continue growing. This is not only a financing issue. It affects where companies scale, who captures the value, and who ultimately leads in strategic sectors.
A Strategic Focus
Technologies like AI, quantum computing, advanced manufacturing, and biotech are becoming central to economic growth, and also sovereignty and security. Europe cannot afford to develop these technologies only to see them scaled and controlled elsewhere. SEF is clearly aligned with this reality. It has a targeted and strategic focus:
- Digital and intelligent systems
- Physical and industrial systems
- Life and health sciences
SEF will be able to invest in these strategically important sectors, including technologies with dual-use applications, all essential to Europe’s long-term competitiveness.
A fund built for scale
The SEF has been designed to respond directly to this challenge.
With a target size of around €5 billion, combining €1 billion from the EIC and €4 billion from private investors, the fund aims to bring together capital at a scale that has been missing in Europe. Its role is to support large funding rounds and give companies the means to grow without needing to look outside the region.
Another important aspect is that SEF does not operate in isolation.
Companies backed by the fund are plugged into the wider EIC ecosystem, gaining access to:
- Corporate partnerships
- International markets and trade opportunities
- Business acceleration services and expert support
This matters because scaling also implies access to customers, partners, and global markets
A different approach to investment
What sets SEF apart is its structure and how it intervenes in the market.
It provides direct equity investment into late-stage companies, rather than allocating capital through intermediaries. This enables the fund to play a central role in large financing rounds, with typical investments of around €100 million.
SEF is set up as a dedicated growth fund, focused specifically on companies at the scaleup stage where capital needs are high and timing is critical. This positions it differently from existing instruments based on grants or blended finance.
Its model is also market-driven. The fund is privately managed, co-financed with private investors, and operates with independent decision-making. This allows for faster execution and closer alignment with market conditions.
Taken together, this approach introduces a model that has so far been largely missing in the European funding landscape.
How SEF differs from existing EIC programmes
SEF builds on the existing EIC framework but targets a very different stage of company growth.
Programmes like the EIC Accelerator focus on startups and early funding stage SMEs, supporting technology development and initial market entry with smaller equity tickets (€10M-€30M). The EIC STEP Scale Up instrument supports companies that have already secured initial investment and are expanding, typically with mid-sized rounds.
SEF sits beyond both. It is designed for companies that are already established and now need to scale at a much larger level, with investment tickets around €100 million and the ability to anchor very large funding rounds.
This creates a more continuous pathway across the innovation lifecycle.
At a glance
| Programme | Target funding stage | Typical ticket size | Role in the lifecycle |
|---|---|---|---|
| EIC Accelerator | Early funding stage | €1M – €10M (+ grants) | Technology development, early market entry |
| STEP Scale Up | Early Mid funding/growth stage | €10M – €30M | Expansion after initial investment |
| SEF | Late-stage/ Growth Phase | ~€100M direct equity | Large-scale growth and global expansion |
—
The difference is not only in size, but in purpose. Earlier programmes help companies reach the market. SEF is designed to help them grow at scale and compete globally.
Closing a longstanding gap
SEF does not solve every issue in Europe’s innovation system. But it addresses a clear and long-standing gap. If it succeeds in mobilising private capital and supporting large European-led rounds, it could help more companies grow into global leaders while remaining anchored in Europe.
Stay tuned to our blog articles and updates. Follow us on LinkedIn for more funding insights.
